Management of Heart Failure: Time to Consider New Options? - a podcast by ReachMD

CME credits: 0.25

Valid until: 11-09-2021

Claim your CME credit at https://reachmd.com/programs/cme/management-of-heart-failure-time-to-consider-new-options/11457/

Derangements in potassium levels are associated with poor outcomes in patients with heart failure. At the same time, suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapies is associated with an increased risk of death. So how do we as clinicians balance these risks?

This discussion focuses on how providers can maximize the use RAASi therapies in patients with heart failure while simultaneously employing potassium binders to manage hyperkalemia.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD